GlassScriptPhysician profile
Sumana Kommana
NPI 1255782173
$2,878.76
in general payments reported to CMS, 2019-2025
20 companies · $1,075 in 2025
The $1,075 reported for 2025 was more than what 79% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2021: $248 · 2022: $310 · 2023: $561 · 2024: $580 · 2025: $1,075.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,215.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $677.30 | 2019-2025 | Clareon, Rocklatan, Clareon Panoptix Pro |
| Glaukos Corporation | $274.70 | 2021-2025 | Idosetr, Idose |
| Biotissue Holdings INC. | $257.81 | 2021-2024 | |
| Rxsight INC | $244.01 | 2023-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Sun Pharmaceutical Industries INC. | $220.99 | 2024-2025 | |
| Carl Zeiss Meditec USA, INC. | $205.92 | 2023 | Forum |
| Ocular Therapeutix, INC. | $173.22 | 2025 | Dextenza |
| Dompe US, INC. | $156.59 | 2021-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $155.90 | 2024-2025 | Xdemvy |
| Abbvie INC. | $119.35 | 2024-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $98.06 | 2024 | Tecnis Iol |
| Harrow Eye, LLC | $62.62 | 2024-2025 | Vevye |
| Amgen INC. | $53.43 | 2025 | Tepezza |
| Sight Sciences, INC. | $52.64 | 2024-2025 | Omni Surgical System |
| Bausch & Lomb Americas INC. | $41.02 | 2025 | Xiidra, Miebo, Envista Envy Iol |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $20.04 | 2024 | Clearpath, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Allergan, INC. | $17.61 | 2022 | |
| Oyster Point Pharma, INC. | $16.22 | 2022 | |
| Mallinckrodt Hospital Products INC. | $16.01 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumana Kommana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.